A view of the headquarters of Novartis in Basel, January 17, 2008. Lotrel, a pill combining two blood pressure drugs in one, was so effective at preventing heart attacks and other problems in a clinical trial that the study was stopped early, and its findings may change the way hypertension is treated, U.S. researchers said on Monday. (Christian Hartmann/Reuters)Reuters - Lotrel, a pill combining two blood
pressure drugs in one, was so effective at preventing heart
attacks and other problems in a clinical trial that the study
was stopped early, and its findings may change the way
hypertension is treated, U.S. researchers said on Monday.